DSW’s Fiscal 4Q17 Results Were a Mixed Bag
DSW posted sales of ~$720 million in fiscal 4Q17, which was below the analyst estimate of $728.2 million.
What Analysts Expect for DSW’s Fiscal 4Q17 Sales
DSW (DSW) is slated to report its fiscal 4Q17 results on March 13, 2018.
Analyzing DSW’s Valuation
As of January 10, DSW (DSW) was trading at a 12-month forward PE (price-to-earnings) multiple of 13.0x. Following the fiscal 3Q17 results, DSW’s valuation multiple has increased 2.4%.
Chilton Investment Company sells its shares in CarMax in 4Q13
Chilton liquidated its position in CarMax Inc. (KMX) in the fourth quarter that had accounted for 0.71% of the fund’s third quarter portfolio.
Chilton Investment Company sells its shares in Genesco
Chilton exited its position in Genesco Inc. (GCO), which had accounted for 1.15% of the fund’s third quarter portfolio.
Chilton Investment Company buys a new stake in US Bancorp
Chilton initiated a new position in the multi-state financial holding company U.S. Bancorp (USB) that accounts for 0.92% of the fund’s fourth quarter portfolio.
Chilton opens a new position in Abbott Laboratories in 4Q13
Abbott Laboratories (ABT) is a brand new position that accounts for 1.19% of Chilton’s fourth quarter 2013 portfolio.
Must-know: Chilton Investment’s Company’s 4Q13 positions
The firm says on its website that it has evolved from managing one long-short equity strategy to managing numerous strategies across various sectors globally.